The power of polypills: Rethinking CKD therapy — a WCN’26 plenary with Anthony Rodgers
Anthony Rodgers has led the development of a groundbreaking and affordable four-in-one cardiovascular “polypill” and directed major clinical trial programs in both developed and developing countries. At WCN’26, he will deliver the plenary lecture, “The potential of polypills in CKD,” exploring how polypills could simplify therapies, improve adherence, and reduce cardiovascular risk in people living with chronic kidney disease.
Register for WCN’26 at early bird rates
Professor Rodgers is acting director of the Cardiovascular Division at The George Institute (Australia) and chair of clinical epidemiology at Imperial College London.
